相关实验视频

Updated: Jul 17, 2025

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

TSC2无活化,低突变负担和高巨细胞透率是肝血管血管脂质瘤的特征

Krinio Giannikou^1,2,3, Katarzyna Klonowska^1,2, Junko Tsuji⁴

¹Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

|September 7, 2023

概括

肝血管肌脂瘤 (hAML) 始终显示TSC2无活化突变和较低的体质突变率. 这些瘤表现出非新生性炎症细胞,主要是巨细胞的显著透.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

已知肝血管肌脂瘤 (hAML) 携带TSC1或TSC2的失活突变,导致mTORC1过度激活.
其他遗传事件和瘤微环境 (TME) 在hAML发育中的作用仍然在很大程度上是未知的.

研究的目的:

为了确定额外的体质遗传事件,有助于hAML瘤发生.
在hAML中描述瘤微环境 (TME) 和免疫细胞透.

主要方法:

零星hAML瘤的外体测序和TSC2.2的向测序.
对15种蛋白质进行免疫组织化学和多重免疫光,以分析TME和免疫细胞.

主要成果:

在83%的hAML病例中发现了TSC2中无活化的体质变异.
观察到其他体变异的发病率较低 (每种瘤中位数为9),大多具有不确定意义.
瘤微环境分析显示了丰富的CD68+巨细胞和耗尽的T细胞的低透率 (PD-1+/PD-L1+,FOXP3+,CD8+).

结论:

hAML瘤的特点是一致的TSC2失活突变和低的整体体质突变率.
hAML 呈现出非新生性炎症细胞的显著透,主要是巨细胞.
这些发现提供了对hAML.的遗传景观和免疫微环境的见解.

关键词:

在PEComa中,我们可以使用PEComa.免疫细胞免疫细胞马赛克马赛克马赛克身体突变是体质突变.这是零星的零星.瘤微环境是一个微环境.

更多相关视频

A Macrophage-Tumor Spheroid Co-Invasion Assay

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...